Star Health & Allied Insurance Company Ltd
₹455.90
(1.08%)
Tue, 17 Mar 2026, 09:37 pm
Star Health & Allied Insurance Company Ratios
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 0 | 0 | 49.81 | 38.28 | 32.80 |
| Price to book ratio | 0 | 0 | 0 | 0 | 0 | 6.42 | 4.59 | 4.80 | 2.98 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | 3.74 | 2.55 | 2.31 | 1.31 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 0 | 1370 | 25.65 | 25.49 | 15.84 |
| Enterprise value | 0 | 0 | 0 | 0 | 0 | 403.73B | 312.82B | 328.14B | 216.56B |
| Enterprise value to EBITDA ratio | - | - | - | - | - | - | - | - | - |
| Debt to equity ratio | 0 | 0.24 | 0.18 | 0.13 | 0.06 | 0.11 | 0.07 | 0.07 | 0.07 |
| Return on equity % | 0 | 16.52 | 10.59 | 15.98 | -37.01 | -19.65 | 9.56 | 12.81 | 9.46 |
Star Health & Allied Insurance Company Ltd Ratios
The Star Health & Allied Insurance Company Ltd Ratios page provides a complete fundamental analysis of Star Health & Allied Insurance Company Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Star Health & Allied Insurance Company Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Star Health & Allied Insurance Company Ltd (NSE: STARHEALTH, BSE: 543412) is currently trading at ₹455.90, with a market capitalization of ₹265.72B. As a major player in the Finance sector and Life/Health insurance industry, Star Health & Allied Insurance Company Ltd remains a key stock for fundamental analysis using Star Health & Allied Insurance Company Ltd Ratios.
Star Health & Allied Insurance Company Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Star Health & Allied Insurance Company Ltd P/E ratio currently stands at 32.80, making it one of the most tracked metrics in Star Health & Allied Insurance Company Ltd Ratios.
Historically, the Star Health & Allied Insurance Company Ltd P/E ratio has shown strong fluctuations:
- 2024: 32.80
- 2023: 38.28
- 2022: 49.81
- 2021: 0
- 2020: 0
The decline in Star Health & Allied Insurance Company Ltd P/E ratio suggests improving earnings relative to stock price.
Price to Book Ratio (P/B)
The Star Health & Allied Insurance Company Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.98.
Historical P/B trend:
- 2024: 2.98
- 2023: 4.80
- 2022: 4.59
- 2021: 6.42
Star Health & Allied Insurance Company Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Star Health & Allied Insurance Company Ltd P/S ratio currently stands at 1.31, an important part of Star Health & Allied Insurance Company Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 1.31
- 2023: 2.31
- 2022: 2.55
- 2021: 3.74
A stable or declining Star Health & Allied Insurance Company Ltd P/S ratio indicates cautious market sentiment.
Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio (P/CF)
The Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 15.84.
Historical Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio:
- 2024: 15.84
- 2023: 25.49
- 2022: 25.65
- 2021: 1370
- 2020: 0
The declining Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Star Health & Allied Insurance Company Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Star Health & Allied Insurance Company Ltd EV currently stands at ₹216.56B, representing the total company valuation including debt.
Historical EV trend:
- 2024: 216.56B
- 2023: 328.14B
- 2022: 312.82B
- 2021: 403.73B
Star Health & Allied Insurance Company Ltd enterprise value consolidation suggests stable valuation.
EV/EBITDA Ratio
The Star Health & Allied Insurance Company Ltd EV/EBITDA ratio is currently 0, a key metric in Star Health & Allied Insurance Company Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
Stable Star Health & Allied Insurance Company Ltd EV/EBITDA indicates balanced valuation.
Star Health & Allied Insurance Company Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Star Health & Allied Insurance Company Ltd D/E ratio is currently 0.07, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.07
- 2023: 0.07
- 2022: 0.07
- 2021: 0.11
Star Health & Allied Insurance Company Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Star Health & Allied Insurance Company Ltd ROE currently stands at 9.46%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 9.46
- 2023: 12.81
- 2022: 9.56
- 2021: -19.65
Declining ROE indicates pressure on profitability.
Star Health & Allied Insurance Company Ltd Ratios Analysis Summary
The Star Health & Allied Insurance Company Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Star Health & Allied Insurance Company Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Star Health & Allied Insurance Company Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800